You are here: All Products  > BeiGene Enters $269 Million Agreement for BioAtla's CTLA-4 Inhibitor

BeiGene Enters $269 Million Agreement for BioAtla's CTLA-4 Inhibitor

Price: $5.00
Available

Get instant access to this article for unlimited viewing and/or downloading for seven days.


Back to products